COVID Symptoms

There are so many things we have yet to learn about the novel coronavirus. What we do know is that it
can be extremely dangerous, spreading more easily than the flu and sometimes even becoming deadly.
Through patient accounts, observations of experienced healthcare professionals and essential clinical
research, we continue to discover information about more ways the coronavirus can manifest itself and
what it can mean in the long-term.
One of the areas to which we need to pay particular attention for the purpose of gathering valuable
intelligence about this virus is symptoms. Symptoms can indicate an onset of COVID-19, and we have
learned that the earlier we are able to determine that someone has contracted COVID-19 and treat it,
the better the outcome tends to be. Identifying COVID-19 symptoms can also help us to isolate infected
patients earlier, limiting transmission of COVID-19.
We also know that symptoms can vary greatly from COVID-19 patient to patient. Some people take
longer to develop COVID-19 symptoms than others; the symptoms of COVID-19 themselves can be
completely different in different people; and some people may suffer from COVID-19 symptoms much
longer or more severely than others. The average person will exhibit COVID-19 symptoms in around 5-6
days after becoming infected with coronavirus, although it can take as little as 2 days and as long as 14
According to the World Health Organization, the most common symptoms of COVID-19 are an elevated
temperature, dry cough and fatigue. COVID-19 symptoms can also include body aches and pains, sore
throat, runny nose, diarrhea, itchy eyes, conjunctivitis, loss of taste or smell, skin rash, discoloration of
fingers and/or toes, shortness of breath…and, in more severe COVID-19 cases, difficulty breathing, chest
pain or pressure, confusion, loss of memory and even loss of speech and/or movement.
Let’s take a closer look at these some of these more concerning symptoms, shall we?
Encephalopathy caused by the virus or simply impaired respiratory function lowering the flow of oxygen
to the brain can cause headaches, fogginess, confusion, inability to wake, memory loss and even
Lethargy and the sudden inability to complete simple day-to-day tasks may also be a sign that a person
has become infected with the coronavirus. This can also manifest in the form of drowsiness, tired, heavy
limbs or the reluctance or inability to move.
Although not the most widely reported symptoms of COVID-19, loss of taste or smell can indicate that a
person has been infected with the coronavirus. It was originally though that loss of taste or smell is
more typical in people who are experiencing a mild version of the disease. However, these symptoms
could be overlooked in someone simultaneously experiencing more severe respiratory symptoms.

And while we know that the virus and its symptoms can more severely affect the senior population,
African American and Latino communities, as well as those who suffer from immunity issues, obesity
and respiratory conditions; some early research seems to indicate that COVID-19 affects certain age
groups of women more severely than men. Certain initial studies, that still require more review, have
reported that women between the age of 40 and 50 typically experience longer lasting effects of COVID-
19 than their male counterparts; and women in the 50- to 60-year-old range are 8 times more likely to
develop lingering COVID-19 symptoms than 18- to 30-year-olds. Men and women over 60 years of age
seem to experience more similar effects of COVID-19.
Regardless of age or gender, research is indicating that a growing number of people are suffering for
months with COVID-19 symptoms, but since this is all new to us, the length and extent to which people
suffer from symptoms is not fully understood. In fact, COVID-19 researchers are still working diligently
to determine if certain people originally believed to have contracted the coronavirus twice are simply
long-haulers with lingering COVID-19 symptoms.
According to the CDC, these lingering symptoms can include fatigue, breathing problems, difficulty
concentrating, headache, muscle or body aches, difficulty sleeping (which could also be due to the stress
one can experience after contracting the virus), dizziness or vertigo, memory issues, coughing and the
inability to exercise or just to be active.
Some symptomatic people also reported continued vision impairment, chest heaviness, drastic heart
rate changes or oxygen levels, sore throat, heart palpitations, rapid hot flashes, joint pain, overheating
with no fever, tremors, tinnitus, rush, reflux, nausea, dry mouth, excessive thirst, mild fever, irritability
or sadness. Some have even reported these symptoms to last well over three months…so far.
Inarguably, there is still a lot we need to learn about COVID-19, so that we can prevent against it, be
better prepared to fight it and to reduce or eliminate the deaths caused by COVID-19. Clinical research
and the findings that are uncovered within the clinical trial process are vital to increasing our knowledge
of all that surrounds COVID-19.
The medical and research professionals at Riverside Clinical Research are scheduling research studies for
COVID-19. If you are interested in becoming a clinical research volunteer and joining the fight against
COVID-19, call the professionals at Riverside Clinical Research for more information at 386-428-7730
Monday through Thursday from 7 a.m. to 5 p.m. or Friday from 7 a.m. to 12 p.m.; or email your
questions to You can also learn more about the clinical research
trials at Riverside Clinical Research by accessing our patient portal which can be found on our website.
An award-winning research facility, Riverside Clinical Research, has earned a stellar reputation for
clinical research trial trendsetting. Riverside Clinical Research doctors and experienced research
professionals work closely with clinical trial volunteers to monitor and assess the benefits and
effectiveness of certain treatment. Deemed one this area’s best medical research facilities, Riverside
Clinical Research can support up to 26 in-house patients and a large number of outpatients. Riverside
Clinical Research is conveniently located at 1410 S. Ridgewood Avenue in Edgewater.